Observed arrival · 2026-09-21
Vivarium Nanoscience’s Three-Model Drug Lab
A Lund-based drug discovery service that tests compounds and nanoparticle-delivered drugs in human organoids, zebrafish, and snail nervous systems.
- For
- Pharmaceutical and biotech development teams
- Worth noticing
- Every particle batch is described as logged, characterised, and released only when it meets defined acceptance limits.
Field notes
The described workflow links formulation design to controlled synthesis, batch characterisation, and testing, with only in-specification batches moving into living systems. The model set combines human organoids with zebrafish and a snail nervous system, allowing the site to present tissue, whole-organism, and neural observations within one service. The company also says it can test compounds without its own nanotechnology, providing a comparison between native and nanoparticle-delivered forms.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue